NCI Cancer Bulletin for November 29, 2011

November 29, 2011 • Volume 8 / Number 23

Read the NCI Cancer Bulletin

The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.

News

Read This Issue


  • Featured Article: Researchers Uncover New Mechanism of Resistance to Melanoma Drug »
  • Survey of Oncologists Suggests Lack of Progress in Cancer Pain Management »
  • Trial Confirms Efficacy of HPV Vaccine, Shows Cross-Protection »
  • Genetic Study Yields Clues to Neuroendocrine Prostate Cancer »

Commentary

Read This Issue


  • A Conversation with Dr. Mason Bond on Improving the Treatment of Patients
    with Ewing Sarcoma »

In Depth

Read This Issue


  • Study Raises Concerns about Using Cancer Cell Lines to Test Drug Resistance »
  • Unexpected Complications: Treating Cancer during Pregnancy »
  • Interpreting Risk: Direct-to-Consumer Genetic Testing »
  • Featured Clinical Trial: Novel Combination Chemotherapy for Localized Ewing Sarcoma »

Updates

Read This Issue


  • FDA Update »
  • Notes »

Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.   

 

NCI Cancer Bulletin for November 15, 2011

November 15, 2011 • Volume 8 / Number 22

Read the NCI Cancer Bulletin

The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.

Commentary

Read This Issue


  • Guest Commentary by Dr. Rachel Ballard-Barbash: The Emerging Evidence about the Role of Obesity in Cancer »

Features

Read This Issue


  • Uncovering the Mechanisms Linking Obesity and Cancer Risk »
  • Searching for Clues to Obesity among the Body's Many Microbes »
  • Bridging Disciplines to Study Possible Cancer-Obesity Links »
  • The Right Balance: Helping Cancer Survivors Achieve a Healthy Weight »
  • Learn More: Additional Information and Resources »

News Highlights

Read This Issue


  • Protein May Regulate Hormone Sensitivity in Breast Cancer »
  • Epigenetic Therapy Shows Potential in Advanced Lung Cancer »
  • Treatment Uses Antibodies and Light to Target Cancer Cells »
  • Genetic Mutation that Raises Melanoma Risk Identified »

Updates

Read This Issue


  • FDA Update »
  • Notes »

Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.   

 

NCI Cancer Bulletin for November 1, 2011

November 1, 2011 • Volume 8 / Number 21

Read the NCI Cancer Bulletin

The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.

News

Read This Issue


  • Featured Article: Organ Transplant Recipients Are at Increased Risk for a Range of Cancers » 
  • Annual Screening with Chest X-Ray Does Not Reduce Lung Cancer Deaths » 
  • Radiation Therapy after Breast-Conserving Surgery Improves Survival » 
  • Targeted Therapy Shows Benefit in Rare Type of Thyroid Cancer » 
  • Study Confirms Letrozole Prevents More Breast Cancer Recurrences than Tamoxifen » 
  • Study Suggests Smaller Melanoma Excision Margins May Be Option for Some Patients » 
  • HPV Vaccine Reduces Anal HPV Infection and Precancerous Lesions » 

In Depth

Read This Issue


  • Study Shows Aspirin Reduces Colorectal Cancer in Those at High Risk » 
  • Tackling the Conundrum of Cachexia in Cancer » 
  • Featured Clinical Trial: Cetuximab and Radiotherapy for HPV-Associated Oropharynx Cancer » 

Updates

Read This Issue